Table 3.
Covariate | Value |
||
---|---|---|---|
Adultsa | Pediatric patientsb | Total | |
Body wt (kg) | |||
n | 51 | 176 | 227 |
Mean | 70.7 | 33.5 | 41.9 |
Range | 49.7–97.1 | 2.6–122 | 2.6–122 |
Age (yr) | |||
n | 51 | 176 | 227 |
Mean | 36.3 | 9.17 | 15.3 |
Range | 22–64 | 0.33–21 | 0.33–64 |
ART status (no. of patients) | |||
Naïve | 40 | 80 | 120 |
Experienced | 11 | 96 | 107 |
RTV comedication (no. of patients) | |||
Without RTV | 28 | 82 | 110 |
With RTV | 23 | 94 | 117 |
Formulation (no. of patients) | |||
Capsule | 51 | 112 | 163 |
Powder | 0 | 64 | 64 |
Sex (no. of patients) | |||
Female | 16 | 88 | 104 |
Male | 35 | 88 | 123 |
Race (no. of patients) | |||
White | 15 | 37 | 52 |
Black | 34 | 116 | 150 |
Other | 2 | 23 | 25 |
Region (no. of patients) | |||
Africa | 31 | 60 | 91 |
North America | 11 | 116 | 127 |
Europe | 9 | 0 | 9 |